Beyond Assessment of Quality of Life in Schizophrenia (eBook)
XIII, 224 Seiten
Springer International Publishing (Verlag)
978-3-319-30061-0 (ISBN)
Dr. A. George Awad is a professor emeritus in the Department of Psychiatry and the Institute of Medical Science, University of Toronto, Canada. Until recently, Dr. Awad served as the Founding President of the International Society of CNS Clinical Trials Methodology, and also as the Psychiatrist-in-Chief of Humber River Hospital, in Toronto. He is the recipient of numerous awards, including the Canadian College of Neuropsychopharmacology Medal for meritorious contributions to neuropsychopharmacology, the Joey and Toby Tanenbaum Award for distinguished researcher in schizophrenia, and, recently, the Andrew C. Leon Distinguished Career Award in CNS clinical trial methodology and neurosciences. Over his forty-five years of academic and research contributions, Dr. Awad dedicated his research focus on the 'person' behind the illness and the outcomes that matter most to the patient.
Dr. Lakshmi N.P. Voruganti joined Dr. Awad as both a Master's and PhD candidate, and made significant contributions exploring and extending Dr. Awad's early research contributions, particularly in the area of neurobiology of subjective tolerability to antipsychotic medications. After gaining his PhD degree, he pursued an independent clinical research career as an associate professor at the University of Western Ontario, London, Ontario, Canada and, later, at McMaster's University in Hamilton, Ontario. At present, he is a practicing psychiatrist at Oakville-Trafalgar Memorial Hospital in Oakville, Ontario, Canada.
Dr. A. George Awad is a professor emeritus in the Department of Psychiatry and the Institute of Medical Science, University of Toronto, Canada. Until recently, Dr. Awad served as the Founding President of the International Society of CNS Clinical Trials Methodology, and also as the Psychiatrist-in-Chief of Humber River Hospital, in Toronto. He is the recipient of numerous awards, including the Canadian College of Neuropsychopharmacology Medal for meritorious contributions to neuropsychopharmacology, the Joey and Toby Tanenbaum Award for distinguished researcher in schizophrenia, and, recently, the Andrew C. Leon Distinguished Career Award in CNS clinical trial methodology and neurosciences. Over his forty-five years of academic and research contributions, Dr. Awad dedicated his research focus on the “person” behind the illness and the outcomes that matter most to the patient.Dr. Lakshmi N.P. Voruganti joined Dr. Awad as both a Master’s and PhD candidate, and made significant contributions exploring and extending Dr. Awad’s early research contributions, particularly in the area of neurobiology of subjective tolerability to antipsychotic medications. After gaining his PhD degree, he pursued an independent clinical research career as an associate professor at the University of Western Ontario, London, Ontario, Canada and, later, at McMaster’s University in Hamilton, Ontario. At present, he is a practicing psychiatrist at Oakville-Trafalgar Memorial Hospital in Oakville, Ontario, Canada.
Part I:Basic and Conceptual Issues.- Schizophrenia and it’s sequelae.- Issues that slowed progress in the assessment of health-related quality of life in schizophrenia.- Social cognition and health-related quality of life in schizophrenia.- Conceptual issues in cultural adaptation and the role of culture in assessment of health-related quality of life in schizophrenia.- Part II:Methodological Issues.- A review of quality of life assessment measures in schizophrenia – limitations and future developments – a review.- Assessment of burden of care and quality of life of caregivers in schizophrenia.- Electronic technology and advances in assessment of outcomes.- Modern psychometric approaches to analysis of scales for health-related quality of life.- Part III:Beyond Assessment of Quality of Life in Schizophrenia.- Health-related quality of life as an outcome and mediator of other outcomes.- Using routine quality of life assessment to improve effectiveness of community mental health care.- Quality of life assessments in the development and clinical trials of new antipsychotics – pharmaceutical industry perspective.- Quality of life and health-costs – the feasibility of cost-utility analysis in schizophrenia.- Health-related quality of life in schizophrenia: health policy and resource allocation.- Beyond assessment of quality of life in schizophrenia: cultural, clinical and research perspectives from India – a case study.- Part IV:Reinventing Quality of Life in Schizophrenia.- Concluding remarks and future challenges.
Erscheint lt. Verlag | 14.6.2016 |
---|---|
Zusatzinfo | XIII, 224 p. 12 illus., 6 illus. in color. |
Verlagsort | Cham |
Sprache | englisch |
Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete |
Medizin / Pharmazie ► Pharmazie | |
Schlagworte | conceptual models • Cultural Adaptation • Electronic Technology • Integration of quality of life assessments in care plans • outcomes • psychopathology • Psychopharmacology • Public health policy and Pharmacoeconomics • Scale development • Social Cognition |
ISBN-10 | 3-319-30061-X / 331930061X |
ISBN-13 | 978-3-319-30061-0 / 9783319300610 |
Informationen gemäß Produktsicherheitsverordnung (GPSR) | |
Haben Sie eine Frage zum Produkt? |
Größe: 4,2 MB
DRM: Digitales Wasserzeichen
Dieses eBook enthält ein digitales Wasserzeichen und ist damit für Sie personalisiert. Bei einer missbräuchlichen Weitergabe des eBooks an Dritte ist eine Rückverfolgung an die Quelle möglich.
Dateiformat: PDF (Portable Document Format)
Mit einem festen Seitenlayout eignet sich die PDF besonders für Fachbücher mit Spalten, Tabellen und Abbildungen. Eine PDF kann auf fast allen Geräten angezeigt werden, ist aber für kleine Displays (Smartphone, eReader) nur eingeschränkt geeignet.
Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen dafür einen PDF-Viewer - z.B. den Adobe Reader oder Adobe Digital Editions.
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen dafür einen PDF-Viewer - z.B. die kostenlose Adobe Digital Editions-App.
Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.
aus dem Bereich